ADCETRIS 50 MG PERF FL
(Brentuximab Vedotin) - Médicament désigné comme "orphelin"
*Treatment of adult patients with relapsed or refractory CD30+ Hodgkin lymphoma (HL):
1. following autologous stem cell transplant (ASCT) or
2. following at least two prior therapies when ASCT or multi-agent chemotherapy is not a treatment option.
*Treatment of adult patients with relapsed or refractory systemic anaplastic large cell lymphoma (sALCL).